ICU Girisim Sermayesi Yatirim Ortakligi A.S.
ICU Girisim Sermayesi Yatirim Ortakligi A.S. is a venture capital investment trust specializing in seed/startup, early, mid venture, middle market, buyouts, PIPEs investments in small and medium enterprises. The fund seeks to invest in healthcare including all areas except hospital services (medical equipment, pharma, distribution, logistics, consumables, IT, laboratories, insurance, and payment … Read more
ICU Girisim Sermayesi Yatirim Ortakligi A.S. (ICUGS) - Total Liabilities
Latest total liabilities as of June 2024: TL58.13 Million TRY
Based on the latest financial reports, ICU Girisim Sermayesi Yatirim Ortakligi A.S. (ICUGS) has total liabilities worth TL58.13 Million TRY as of June 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
ICU Girisim Sermayesi Yatirim Ortakligi A.S. - Total Liabilities Trend (2021–2024)
This chart illustrates how ICU Girisim Sermayesi Yatirim Ortakligi A.S.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
ICU Girisim Sermayesi Yatirim Ortakligi A.S. Competitors by Total Liabilities
The table below lists competitors of ICU Girisim Sermayesi Yatirim Ortakligi A.S. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Volt Group Ltd
AU:VPRDB
|
Australia | AU$2.16 Million |
|
MYCELX Technologies Corporation
LSE:MYX
|
UK | GBX6.85 Million |
|
Sutton Harbour Holdings plc
LSE:SUH
|
UK | GBX29.53 Million |
|
MANZ (M5Z.SG)
STU:M5Z
|
Germany | €178.44 Million |
|
Cyren Ltd.
PINK:CYRNQ
|
USA | $30.94 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down ICU Girisim Sermayesi Yatirim Ortakligi A.S.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.02 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.15 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.13 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ICU Girisim Sermayesi Yatirim Ortakligi A.S.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ICU Girisim Sermayesi Yatirim Ortakligi A.S. (2021–2024)
The table below shows the annual total liabilities of ICU Girisim Sermayesi Yatirim Ortakligi A.S. from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-06-30 | TL230.96 Million | +435.95% |
| 2023-06-30 | TL43.09 Million | +122.93% |
| 2022-06-30 | TL19.33 Million | +122.35% |
| 2021-06-30 | TL8.69 Million | -- |